Posts by: Anna Tan

Anna Tan

Anna is responsible for the scripting and production of video news content. Her skills as a registered nurse as well as a proven video content creator on YouTube and other social media platforms allow her to create video news reports that are engaging and easy to understand for patients.

October 7, 2015October 7, 2015

AbbVie To Proceed With Phase III Studies For ABT-494 In Rheumatoid Arthritis

News

Global biopharmaceutical company, AbbVie, recently revealed plans to further develop its lead selective JAK1 inhibitor product candidate, ABT-494 in a Phase III clinical study on rheumatoid arthritis (RA). This step ... Read more

September 30, 2015October 1, 2015

RuiYi Doses First Human in Gerilimzumab Study for Rheumatoid Arthritis

News

RuiYi, Inc., a biopharmaceutical company focused on discovering and developing novel antibody-based therapeutics, recently announced it has dosed the first human subject in the study of lead product candidate, Gerilimzumab, a ... Read more

September 18, 2015September 18, 2015

Johns Hopkins Researchers Find Yoga Can Improve Arthritis

News

A fair amount of research on the health benefits of yoga has been conducted thus far, but a team of researchers at Johns Hopkins took extra initiative and designed the largest ... Read more

September 11, 2015September 11, 2015

RA Patients in Europe Welcome Cost-Effective Biosimilars and Urge Agencies to Mandate Biosimilar Use

News

Decision Resources Group, a provider of best-in-class, high-value data, analytics and insights products and services to the healthcare industry, recently conducted a survey of rheumatologists across EU5 (France, Germany, Italy, Spain, and ... Read more

September 9, 2015September 9, 2015

FDA Approves Revised SIMPONI ARIA Label to Include Improvement in Physical and Emotional Measures in Rheumatoid Arthritis

News

Janssen Biotech, Inc. recently announced the US Food and Drug Administration has approved the company’s Supplemental Biologics License Application (sBLA) for SIMPONI ARIA (golimumab for infusion), a treatment of moderately to severely ... Read more

July 24, 2015July 24, 2015

Many Autoimmune Arthritis Patients Experience Delayed Diagnoses

News

According to a recently published study by the International Foundation for Autoimmune Arthritis (IFAA), a multinational not-for-profit organization, established textbook symptoms of Autoimmune Arthritis (AIA) onset are not in line with ... Read more

July 10, 2015July 10, 2015

Rheumatoid Arthritis Treatment Market to Grow Tighter Until 2020, Report Says

News

Reportlinker recently published an industry report on today’s rheumatoid arthritis market, titled, “Rheumatoid Arthritis Market to 2020 – A Crowded Market Characterized by Modest Growth,” which also covers market predictions until ... Read more

July 8, 2015July 8, 2015

Single-Shot Rheumatoid Arthritis Treatment Shows Promise in Early Clinical Trial

News

A team of scientists from the University of Queensland have just established the world’s first vaccine-style approach to treat rheumatoid arthritis (RA), an autoinflammatory disease of the joints that affects over ... Read more

July 6, 2015July 6, 2015

Survey Results Urge FDA to Review Biosimilars for Rheumatoid Arthritis

News

The Coalition of State Rheumatology Organizations, the country’s authority on state rheumatology society activities, recently conducted a survey of registered rheumatologists. The survey results revealed that while most of them are eager ... Read more

December 11, 2014December 11, 2014

How to Know and Manage Early Warning Signs of Rheumatoid Arthritis

News

Barbara Griffin, NMD, CNC, Certified Gluten Practitioner and Director of Vital Health, Inc., believes the earlier symptoms of rheumatoid arthritis are managed, the better the disease outcome and odds that ... Read more